How many insider trades does FilingIQ track for MANE?

FilingIQ tracks 78 Form 4 insider transactions for MANE (Veradermics, Inc), covering filings from Feb 3, 2026 onwards. 2 of those were filed in the last 90 days.

Are MANE insiders net buyers or net sellers?

Across the full Form 4 history for MANE, 27 transactions (35%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MANE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MANE in?

Veradermics, Inc (MANE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.57B.

MANE insider trading

Healthcare

Veradermics, Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

35% / 0%

Market cap

$1.57B

About Veradermics, Inc

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut.

Company website: www.veradermics.com

MANE insider activity at a glance

FilingIQ has scored 78 insider transactions for MANE since Feb 3, 2026. The most recent filing in our index is dated May 1, 2026.

Across the full history, 27 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MANE insider trades is 63.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MANE trades on FilingIQ Raw filings on SEC EDGAR

Latest MANE Form 4 filings

Longitude Capital Partners V, LLC

P Feb 5, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC

P Feb 5, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading MANE

Coric Vlad

23 trades · score 70.8

Frequently asked

How many insider trades does FilingIQ track for MANE?: FilingIQ tracks 78 Form 4 insider transactions for MANE (Veradermics, Inc), covering filings from Feb 3, 2026 onwards. 2 of those were filed in the last 90 days.
Are MANE insiders net buyers or net sellers?: Across the full Form 4 history for MANE, 27 transactions (35%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MANE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MANE in?: Veradermics, Inc (MANE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.57B.

Methodology & sources

Every MANE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.